New Corona "Recovery Hemorrhage Treatment" Administered to 6 Clinical Research Report November 10, 20:27
A symposium of the National Center for Global Health and Medicine, which is in charge of treatment at the forefront of the new coronavirus, was held online on the 10th, and the "recovery hemorrhagic treatment" that administers the blood components of the recovered person to another patient The latest status of clinical research was reported.
This symposium was held by the National Center for Global Health and Medicine, and researchers and doctors from Japan and overseas participated in the report on the epidemic situation and the latest development status of vaccines and treatment methods.
Of these, Dr. Satoshi Kutsuna of the National Center for Global Health and Medicine gave a clinical study of "recovery hemorrhage treatment" in which "blood plasma" containing antibodies is taken out from the blood of a recovered person and administered to another patient. The latest status has been reported.
According to this, 97 recoverers have provided blood ginger so far, and a total of 6 men in their 30s and 60s have been given blood ginger.
Since no abnormalities are seen in any of the patients at present, it is to be administered to a total of about 60 patients with moderate or higher respiratory condition, and the safety and efficacy will be judged.
"Recovery hemorrhagic treatment" is permitted for emergency use in the United States, but has not yet been approved in the country.
In the lecture, Dr. Kutsuna said, "First of all, it is important to evaluate the safety. We are looking for recoverers who can provide blood, so we would like to proceed with further research." ..